Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on October 4, 2006
J Am Soc Nephrol 17: 3082-3092, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2005101077

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005101077v1
17/11/3082    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jo, S.-K.
Right arrow Articles by Kim, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jo, S.-K.
Right arrow Articles by Kim, H. K.

Pathophysiology of Renal Disease and Progression

Heat Preconditioning Attenuates Renal Injury in Ischemic ARF in Rats: Role of Heat-Shock Protein 70 on NF-{kappa}B–Mediated Inflammation and on Tubular Cell Injury

Sang-Kyung Jo, Gang Jee Ko, Chang Su Boo, Won Yong Cho and Hyoung Kyu Kim

Division of Nephrology, Department of Internal Medicine, Institute of Renal Disease, Korea University Hospital, Seoul, Korea

Address correspondence to: Dr. Won Yong Cho, Division of Nephrology, Department of Internal Medicine, Korea University Hospital, 126-1, 5Ka, Anam-Dong, Sungbuk-Ku, Seoul, Korea 136-705. Phone: +82-2-920-5599; Fax: +82-2-927-5344; E-mail: wonyong{at}korea.ac.kr

Received for publication October 18, 2005. Accepted for publication August 24, 2006.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
Although heat preconditioning has been known to be protective in various types of injury, the precise molecular mechanism for this is unclear. Recent observations that indicate that previous heat shock has an anti-inflammatory, antiapoptotic effect led to this investigation of the in vivo effect of heat preconditioning on NF-{kappa}B activation and inflammation and also on tubular cell injury in ischemic acute renal failure (ARF). Heat preconditioning provided marked functional protection and also reduced histologic evidence of tubular necrosis. Ischemia/reperfusion–induced NF-{kappa}B activation was suppressed by heat preconditioning with a subsequent decrease in monocyte chemoattractant protein-1 expression and inflammatory cell infiltration. Heat preconditioning also suppressed the accumulation of phosphorylated inhibitory {kappa}B{alpha} (I{kappa}B{alpha}) with a resultant depletion of cytoplasmic I{kappa}B{alpha}, indicating that heat preconditioning blocked the activation of the I{kappa}B kinase complex. Tubular cell apoptosis, determined by terminal deoxynucleotidyl transferase–mediated dUTP nick-end labeling staining, also was decreased by heat preconditioning, and this was accompanied by decreased caspase 3 activation. Among several heat-shock proteins (HSP), HSP-70 was induced primarily by heat preconditioning. Inhibition of HSP-70 by quercetin almost completely reversed the functional protection that was provided by heat preconditioning. These data provide evidence that HSP-70 affords protection via inhibition of NF-{kappa}B–mediated inflammation and also inhibition of the cell death pathway in ischemic ARF. Further elucidation of the cytoprotective mechanism of stress proteins could facilitate new target or drug development in the treatment of ARF.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
Ischemic acute renal failure (ARF) is a major clinical problem whose mortality rate still is >30% despite advances in supportive care. It also is associated with initial delayed graft function, which might result in poor long-term graft function (1,2). The pathophysiologic mechanism of ischemic ARF is thought to include a complex interplay among vascular endothelial cell dysfunction, inflammation, and tubular cell damage. Inflammation is thought to contribute to tissue damage by releasing several mediators, such as proinflammatory cytokines, proteases, and eicosanoids (3). Tubular cell apoptosis, morphologically characterized by chromatin condensation, cell shrinkage, and plasma membrane blebbing, also is known to play an important role in renal dysfunction (4,5).

NF-{kappa}B is a ubiquitous, inducible transcription factor that regulates the expression of numerous genes, particularly those that are involved in inflammatory processes (6). Several recent reports indicated that the NF-{kappa}B pathway is activated after ischemia/reperfusion (I/R) and that several proinflammatory cytokine genes are under the transcriptional control of NF-{kappa}B (7,8). Usually, NF-{kappa}B resides in the cytoplasm in an inactive state bound to its inhibitor, inhibitory {kappa}B (I{kappa}B). After various stimuli, phosphorylation and subsequent ubiquitination of I{kappa}B leads to release and nuclear translocation of NF-{kappa}B, where it promotes its gene transcription (9).

The heat-shock response consists of the expression of a family of highly conserved proteins that are known as heat-shock proteins (HSP), and they are well known for their cytoprotective function in a variety of injury models. Although the protective role of heat preconditioning or HSP is thought to be due to their ability to facilitate refolding, assembly, and stabilization of denatured proteins, precise molecular mechanisms of such a beneficial effect are not well established (10,11). Several reports have indicated that the protective effect of HSP-70 is partially mediated through inhibition of NF-{kappa}B pathway–related inflammation, as well as modulation of cell necrosis or apoptosis (1214). Heat preconditioning stabilized I{kappa}B proteins and subsequently suppressed their activation in liver I/R or myocardial inflammation (15,16). In addition, HSP-70 has been demonstrated to be protective in renal tubular cell apoptosis that is induced by inflammatory cytokine or ATP depletion. However, the in vivo effect of heat preconditioning on inflammation and tubular cell necrosis or apoptosis in ischemic ARF has never been examined. The purpose of our study was to examine the effect of heat preconditioning on NF-{kappa}B activation and subsequent inflammation, as well as on tubular cell necrosis, and apoptosis in ischemic ARF in rats. We found that the beneficial effect of heat preconditioning is mediated partially by its inhibitory effect on NF-{kappa}B pathway–mediated inflammation as well as by attenuation of tubular cell apoptosis and necrosis.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
Animals and Experimental Protocol
Male Sprague-Dawley rats that weighed 150 to 200 g were purchased from Orient (Orient Bio Department, Kyungki-Do, Korea) and had free access to water and food before manipulation. Animal care was in accordance with the criteria established by the animal care committee of Korea University for the care and use of laboratory animals in research. Rats were randomly assigned to one of four groups: sham (n = 6), heat preconditioning + sham (HP; n = 6), I/R (n = 6), and heat preconditioning + I/R (HP+I/R; n = 6). For heat preconditioning, rats were anesthetized with an intraperitoneal injection of 100 mg/kg ketamine and 12.5 mg/kg xylazine and placed on a heating pad until their rectal temperature reached and was maintained at 42 ± 0.5°C for 15 min. Sixteen hours after heat preconditioning, ischemic injury was introduced by bilateral clamping of the renal pedicles for 40 min. The animals were kept at a constant temperature (37°C) during this procedure and allowed to recover after intraperitoneal instillation of 1 ml of warmed normal saline. Sham operation was performed in a similar manner, except for clamping of the renal pedicles. At the time of reperfusion and after 1, 6, and 24 h of reperfusion, rats were killed and blood was collected by intracardiac puncture. These time points were selected because NF-{kappa}B activation and subsequent inflammation have been reported to occur early after reperfusion and tubular cell damage becomes evident thereafter. Whole-kidney tissue or bluntly dissected cortex and medulla were processed for molecular and histologic examination. In addition, more complete time-course study of plasma creatinine was done in both groups to determine whether previous heat preconditioning ameliorates or delays renal injury. For another set of experiments, heat preconditioning was introduced as described previously. Rats were killed at 1, 6, and 14 h after heat to determine the degree of expression of various HSP. To define the role of specific HSP in heat preconditioning–induced renal protection, quercetin (20 mg/kg, intraperitoneally; Sigma Aldrich, St. Louis, MO) was administered 1 h before heat, and the rats were killed at 14 h after heat and at 24 h after I/R, respectively.

Biochemical and Histologic Examination
Plasma creatinine levels were measured using a Hitachi 747 automatic analyzer (Tokyo, Japan). For histologic examination, paraformaldehyde-fixed (4%) and paraffin-embedded kidney tissues were stained with periodic acid-Schiff. Histologic changes in the outer medulla were evaluated semiquantitatively. Briefly, tubular damage was estimated in 8 to 10 high-power fields (HPF; x200) per section by using a scoring system based on the percentage of damaged tubules per field (1 = <25%; 2 = 25 to 50%; 3 = 50 to 75%; and 4 = >75%), and the mean scores of each rat were compared. Detection of apoptotic cells in the kidney also was performed on paraffin-embedded kidney tissue sections using ApopTag Plus (Intergen, Purchase, NY), following the manufacturer’s protocol. The number of apoptotic cells in the outer medulla and cortex was measured semiquantitatively by counting 8 to 10 HPF (x200) per section, and the mean number of terminal deoxynucleotidyl transferase–mediated dUTP nick-end labeling (TUNEL)-positive cells was compared between groups. Inflammation was assessed by staining with Naphthol AS-D chloracetate and anti-rat macrophage antibody (ED-1). The number of esterase-positive leukocytes or ED-1–positive mononuclear cells was measured by counting 8 to 10 HPF (x200) in the outer medulla, and the mean number of positive cells was compared between groups.

Preparation of Cytoplasmic and Nuclear Protein Extracts
Cytoplasmic and nuclear protein extracts were prepared using NE-PER Nuclear and Cytoplasmic Extraction Kit (Pierce Biotechnology, Rockford, IL), following the manufacturer’s protocol, and the protein concentration was measured (BCA protein assay reagent; Pierce Biotechnology).

Electrophoretic Mobility Shift Assay
NF-{kappa}B consensus oligonucleotide sequence (5'-AGTGAGGGACTTTCCCAGGC-3'; Promega, Madison, WI) was end-labeled with [{gamma}-32P]ATP (Bio-Rad, Hercules, CA) using T4 polynucleotide kinase (Promega), and unlabeled oligonucleotide was removed by MicroSpin G-25 columns (Amersham, Piscataway, NJ). Nuclear extracts (30 µg) were incubated with 2 µl of 5x binding buffer (Promega). One microliter of labeled probe was added to the reaction mixture and incubated for 20 min at room temperature. HeLa cell nuclear extracts were used as a positive control; the negative control contained no nuclear extract. The specificity of this reaction was confirmed by a competition assay in which 100-molar excess of unlabeled cold NF-{kappa}B (specific inhibition) or activating protein 1 (AP-1) oligonucleotide (nonspecific inhibition) was added 10 min before the addition of the labeled probe. The protein-DNA complexes were separated on 4% nondenaturing polyacrylamide gel and visualized by autoradiography.

Western Blot
Samples of cytoplasmic, nuclear (30 µg), or total (30 µg) protein were separated by 10% SDS-PAGE and then transferred onto a polyvinylidene difluoride membrane. Western blot analysis was performed using primary antibodies for phosphorylated I{kappa}B (phospho-I{kappa}B), HSP-27, HSP-32 (Santa Cruz Biotechnology, Santa Cruz, CA), p65, I{kappa}B-{alpha}, HSP-90 (Cell Signaling Technology, Beverly, MA), or HSP-70 (BD Transduction Laboratories, Greenland, NH). Membranes were washed three times and incubated with appropriate peroxidase-conjugated secondary antibodies. The membranes were stained with Ponceau S (Sigma-Aldrich) to ensure that equal amounts of proteins were loaded.

Quantification of Monocyte Chemoattractant Protein-1 by Real-Time Reverse Transcriptase–PCR
Total RNA from bluntly dissected kidney cortex and medulla was isolated by using TRIZOL reagent (Life Technology, Rockville, MD) according to the manufacturer’s protocol. After precipitation by isopropyl alcohol, total RNA was purified further using RNeasy Minikit (Qiagen, Valencia, CA). One microgram of total RNA was reverse-transcribed in a reaction volume of 50 µl that contained 10x reverse transcriptase buffer, 5.5 mM MgCl2, 500 µM of each dNTP, 2.5 µM random hexamer, 0.4 U/µl RNase inhibitor, and 3.125 U/µl MultiScribe Reverse Transcriptase at 25°C for 10 min, 48°C for 30 min, and 95°C for 5 min (Taqman Reverse Transcription Reagents, Applied Biosystem, Foster City, CA). Subsequently, real-time PCR was run in triplicate on the iCycler system (Bio-Rad) under the amplification condition of 40 cycles of 95°C for 15 s and 60°C for 60 s, with gene-specific primer and probe set designed by Beacon Designer Software (version 2; Bio-Rad) based on sequences from GenBank, which were as follows: sense 5'-GATCTCTCTTCCTCCACCACTATG-3', antisense 5'-GAATGAGTAGCAGCAGGTGAGT-3', and probe 5'-AGGTCTCTGTCACGCTTCTGGGCC-3'. Taqman probes were labeled with 6-carboxy-fluorescein as a reporter dye and 6-carboxy-tetramethyl-rhodamine as a quencher dye. 18S ribosomal RNA (Taqman ribosomal control reagent; Applied Biosystem) was used as an internal control to normalize the data. The dynamic range of each primer/probe set was verified by a serial dilution of cDNA template. The abundance of monocyte chemoattractant protein-1 (MCP-1) gene expression was normalized to that of 18S and was expressed as fold differences relative to sham-operated control rats.

Quantification of MCP-1 Protein by ELISA
Concentration of MCP-1 protein in whole-kidney tissue was measured by ELISA (OptEIA Set Rat MCP-1; BD Biosciences, Palo Alto, CA) according to the manufacturer’s protocol. Briefly, whole-kidney tissues were homogenized in 500 µl of assay diluent (PBS with 10% FBS [pH 7.0]) and centrifuged at 12,000 rpm for 15 min at 4°C. After coating and blocking plates, MCP-1 standards and triplicates of samples were added, followed by incubation with biotinylated anti-rat MCP-1 with avidin–horseradish peroxidase. Absorbance was read at 450 nm, and MCP-1 tissue content was derived from a standard curve and expressed as pg MCP-1/mg protein.

Measurement of Caspase Activity
The activity of caspase 3 in kidney tissue was determined by fluorometric detection of free 7-amino-4-trifluoromethylcoumarine according to the manufacturer’s protocol (ApoAlert Caspase Fluorescence Assay Kit; BD Biosciences) by using Synergy HT Multi-Detection Microplate Reader (Biotek, Woburn, MA). Briefly, kidney tissues were homogenized in 1 ml of lysis buffer, incubated on ice for 10 min, and centrifuged at 15,000 x g for 10 min at 4°C. Supernatants that contained 50 µg of protein were incubated for 1 h at 37°C in the presence of reaction buffer, 1 mmol/L dithiothreitol, and 50 µmol/L 7-amino-4-trifluoromethylcoumarine substrate conjugates. Fluorescence was read at 400/505 nm (excitation/emission), and the samples were run in triplicate. The activity of caspase 3 was expressed as a percentage increase compared with the sham-operated control group, and samples that were incubated with specific caspase inhibitor served as a negative control.

Statistical Analyses
All data are presented as means ± SEM and were analyzed by an unpaired t test. P < 0.05 was considered statistically significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
Heat Preconditioning Afforded Functional and Histologic Renal Protection in Ischemic ARF in Rats
To determine the effect of heat preconditioning in I/R injury, we first evaluated biochemical and histologic renal damage. Plasma creatinine levels at 24, 48, and 96 h after I/R injury were decreased significantly in rats with heat preconditioning compared with those without (2.35 ± 0.39/3.35 ± 0.54/2.65 ± 0.41 versus 0.63 ± 0.13/1.36 ± 0.26/0.99 ± 0.13 mg/dl; P = 0.02, P < 0.01, P < 0.01; Figure 1). Histologic examination showed extensive tubular injury characterized by tubular cell necrosis, dilation of tubules, and cast formation in the outer medulla. However, kidneys from previously heat-treated rats showed less tubular injury than did kidneys from those without heat preconditioning. A semiquantitative assessment of histologic damage, demonstrating a significant beneficial effect of heat preconditioning in I/R-induced renal injury, is shown in Figure 2.


Figure 1
View larger version (10K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Effect of heat preconditioning (HP) on renal function in ischemic acute renal failure (ARF) in rats. Rats were placed on a heating pad for brief HP (42 ± 0.5°C, 15 min) or at room temperature and subjected to 40 min of bilateral renal pedicle clamping at 14 h after heat treatment. At 24, 48, 96, and 144 h after reperfusion, blood samples were collected and creatinine was measured. Data are means ± SEM (n = 6 rats per group). #P < 0.05 versus sham; *P < 0.05 versus ischemia/reperfusion (I/R).

 

Figure 2
View larger version (100K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. Effect of HP on renal histology in ischemic ARF in rats. Rats were placed on a heating pad for brief HP (42 ± 0.5°C, 15 min) or at room temperature and subjected to 40 min of bilateral renal pedicle clamping at 14 h after heat treatment. Twenty-four hours after reperfusion, rats were killed and histologic renal damage was determined. (A) I/R cortex. (B) HP+I/R cortex. (C) I/R medulla. (D) HP+I/R medulla. (E) Semiquantitative assessment of renal damage in medulla (n = 6 per group). *P < 0.05 versus I/R. Magnification, x100 (periodic acid-Schiff [PAS]).

 
Heat Preconditioning Inhibited NF-{kappa}B Activation in Ischemic ARF in Rats
To assess nuclear translocation and binding of NF-{kappa}B, we performed electrophoretic mobility shift assay. NF-{kappa}B activation was already evident at 1 h after reperfusion. Heat preconditioning suppressed the I/R-induced activation of NF-{kappa}B, whereas heat preconditioning itself had no effect on NF-{kappa}B activity. A competition assay, using a 100-molar excess of unlabeled NF-{kappa}B probe or AP-1 probe to show the specificity of reaction, was performed (Figure 3A). Addition of unlabeled NF-{kappa}B probe before the addition of labeled probe (specific inhibitor) reduced gel band intensity, but addition of unlabeled AP-1 probe (nonspecific inhibitor) had no effect. This effect of heat preconditioning on decreasing NF-{kappa}B activation also was confirmed by Western blot of p65 subunit (Figure 3B). Because activation of NF-{kappa}B is known to depend largely on phosphorylation of the serine residue of I{kappa}B and subsequent degradation, cytoplasmic protein levels of I{kappa}B and phosphorylated I{kappa}B were examined. I/R decreased the abundance of I{kappa}B, whereas the abundance of phospho-I{kappa}B was increased. Previous heat preconditioning suppressed the depletion of cytoplasmic I{kappa}B and the accumulation of phospho-I{kappa}B (Figure 3, C and D), indicating that the effect of heat preconditioning is mediated through inhibition of I{kappa}B kinase (IKK), an upstream kinase that determines the phosphorylation of I{kappa}B.


Figure 3
View larger version (61K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 3. Effect of HP on NF-{kappa}B activation in ischemic ARF in rats. Rats were placed on a heating pad for brief HP (42 ± 0.5°C, 15 min) or at room temperature and subjected to 40 min of bilateral renal pedicle clamping at 14 h after heat treatment. Rats were killed at 1 or 6 h after reperfusion. (A) Electrophoretic mobility shift assay (EMSA) for NF-{kappa}B. (B) Western blot of nuclear p65 protein. (C) Western blot of cytoplasmic I{kappa}B-{alpha}. (D) Western blot of cytoplasmic phosphorylated inhibitory {kappa}B{alpha} (p-I{kappa}B{alpha}). For EMSA, HeLa cell nuclear extracts were used as positive control and a free probe was used as negative control. One hundred-molar excess of unlabeled NF-{kappa}B probe and unlabeled activating protein 1 (AP-1) probe served as a specific inhibitor or nonspecific inhibitor, respectively.

 
Heat Preconditioning Suppressed Expression of MCP-1 in Ischemic ARF in Rats
Because several chemokines and cytokines are known to be under the transcriptional control of NF-{kappa}B, we examined the mRNA expression of MCP-1 in bluntly dissected cortex and medulla using real-time quantitative reverse transcriptase–PCR. At 6 h after reperfusion, MCP-1 mRNA expression increased in medulla compared with cortex, and heat preconditioning significantly reduced their expressions (Figure 4A). MCP-1 protein from whole-kidney tissue as measured by ELISA also showed marked reduction by heat preconditioning (Figure 4B).


Figure 4
View larger version (10K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 4. Effect of HP on monocyte chemoattractant protein-1 (MCP-1) expression in ischemic ARF in rats. MCP-1 mRNA and protein expression was measured at 6 h after reperfusion by real-time quantitative reverse transcriptase–PCR (RT-PCR) and ELISA. In real-time RT-PCR, the gene expression level was normalized to that of 18S and expressed as fold differences relative to sham-operated rats. (A) MCP-1 mRNA. (B) MCP-1 protein. Data are means ± SEM (n = 6 rats per group). #P < 0.05 versus sham; *P < 0.05 versus I/R.

 
Heat Preconditioning Reduced Inflammation in Ischemic ARF in Rats
Inflammatory cell recruitment after I/R is facilitated by various mediators such as chemokines, cytokines, and adhesion molecules and is thought to contribute to renal injury. At 24 h after reperfusion, numerous ED-1–and esterase-positive leukocytes were found in the medullary interstitium, but in cortex, very few inflammatory cells were found in both groups. Heat preconditioning significantly reduced the infiltration of inflammatory cells in medulla (Figures 5 and 6).


Figure 5
View larger version (59K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 5. Effect of HP on anti-rat macrophage antibody (ED-1) leukocyte infiltration in ischemic ARF in rats. Eight to 10 high-power fields (HPF; x200) per section were counted, and mean numbers of ED-1–positive leukocytes were compared. (A) Sham cortex. (B) I/R cortex. (C) HP+I/R cortex. (D) Sham medulla. (E) I/R medulla. (F) HP+I/R medulla. (G) Mean numbers of ED-1–positive leukocytes in medulla. Data are means ± SEM (n = 6 rats per group). #P < 0.05 versus sham; *P < 0.05 versus I/R. Magnification, x400 (ED-1 staining, 24 h).

 

Figure 6
View larger version (65K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 6. Effect of HP on esterase-positive leukocyte infiltration in ischemic ARF in rats. Eight to 10 HPF (x200) were counted, and mean numbers of esterase-positive leukocytes were compared. (A) Sham cortex. (B) I/R cortex. (C) HP+I/R cortex. (D) Sham medulla. (E) I/R medulla. (F) HP+I/R medulla. (G) Mean numbers of esterase-positive leukocytes in medulla. Data are means ± SEM (n = 6 rats per group). #P < 0.05 versus sham; *P < 0.05 versus I/R. Magnification, x400 (naphthol AS-D chloracetate esterase staining, 24 h).

 
Heat Preconditioning Reduced Caspase Activation and Apoptosis
Caspases are cysteine proteases that are responsible for apoptosis. Because the in vivo effect of heat preconditioning on apoptosis in ischemic ARF has never been examined, we measured the activation of caspase 3, an executioner caspase, and also apoptosis. Heat preconditioning reduced the activation of caspase 3 at 6 h after I/R injury predominantly in cortex (Figure 7), and this was accompanied by reduced TUNEL-positive cells that also were found mainly in cortical distal tubules (Figure 8). These findings suggest that heat preconditioning decreases caspase 3–mediated apoptosis in ischemic ARF.


Figure 7
View larger version (13K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 7. Effect of HP on caspase activation in ischemic ARF in rats. Caspase 3 activities were measured in cortex and medulla at 6 h after reperfusion and were expressed as percentage increase compared with sham group rats. Samples in which specific caspase inhibitors were added served as negative control for the reactions. Data are means ± SEM (n = 6 rats per group). #P < 0.05 versus sham; *P < 0.05 versus I/R.

 

Figure 8
View larger version (71K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 8. Effect of HP on apoptosis in ischemic ARF in rats. Rats were placed on a heating pad for brief HP (42 ± 0.5°C, 15 min) or at room temperature and subjected to bilateral renal pedicle clamping for 40 min. Detection of apoptosis was done at 24 h. (A) Sham. (B) HP 14 h. (C) I/R. (D) HP+I/R. (E) Mean numbers of terminal deoxynucleotidyl transferase–mediated dUTP nick-end labeling (TUNEL)-positive apoptotic cells. Data are means ± SEM (n = 6 rats per group). #P < 0.05 versus sham; *P < 0.05 versus I/R. Magnification, x200 (TUNEL).

 
HSP-70–Mediated Protective Effect of Heat Preconditioning in Ischemic ARF in Rats
Although heat preconditioning afforded functional and histologic renal protection in this study, the role of individual HSP was not clear. In addition, it is possible that this previous thermal stress might have other, non–HSP-related, nonspecific effects. Therefore, we examined the expression of various HSP. After heat treatment, HSP-70 expression markedly increased, compared with HSP-27, HSP-32, or HSP-90 (Figure 9A). Previous administration of quercetin, a known inhibitor of HSP-70, completely reversed the functional protection that was induced by heat preconditioning (Figure 9B), and this also was accompanied by reversal of p65 subunit downregulation by heat preconditioning (Figure 9C). These data suggest that HSP-70 is responsible for the protective effect of heat preconditioning in this study.


Figure 9
View larger version (36K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 9. Effect of quercetin (Q) on expression of heat-shock proteins (HSP), renal function, and NF-{kappa}B activation in ischemic ARF in rats. Q was administered 1 h before HP, and rats were killed at 1, 6, and 14 h after HP or 24 h after I/R. (A) Western blot of various HSP after heat-shock treatment or Q+heat-shock treatment. (B) Plasma creatinine 24 h after I/R. Data are means ± SEM (n = 6 rats per group). #P < 0.05 versus sham; *P < 0.05 versus I/R; ##P < 0.05 versus HP+I/R. (C) Western blot of nuclear p65 protein 1 h after I/R.

 
HSP-70 Induction by I/R Was Blunted in Heat-Preconditioned Animals
To identify the effect of induced HSP by heat preconditioning on subsequent HSP-70 induction after I/R, we performed Western blot analysis of HSP-70 at 0, 1, and 6 h after I/R. HSP-70 induction was markedly blunted in heat-preconditioned rats at 1 and 6 h compared with normothermic rats (Figure 10).


Figure 10
View larger version (15K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 10. HSP-70 induction after I/R. Rats were placed on a heating pad for brief HP (42 ± 0.5°C, 15 min) or at room temperature and subjected to bilateral renal pedicle clamping for 40 min. Rats were killed at 0, 1, and 6 h after I/R.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
In this study, we have demonstrated that heat preconditioning afforded functional and histologic renal protection in ischemic ARF in rats, and this was accompanied by suppression of NF-{kappa}B activation and subsequent inflammation, as well as tubular cell necrosis and apoptosis. We also found that the beneficial effect of heat preconditioning seems to be mediated primarily through HSP-70 induction.

In the kidney, I/R induces inflammatory mediators such as chemokines, cytokines, and adhesion molecules (17). These mediators are thought to initiate the inflammatory cascade that leads to leukocyte recruitment and microcirculatory compromise with resultant renal dysfunction. Because these mediators, such as TNF-{alpha} and MCP-1, are known to have {kappa}B-binding motifs in their promoter regions, their transcriptions are thought to be under the control of NF-{kappa}B (9,18). Therefore, NF-{kappa}B may be a potential therapeutic target in ischemic ARF.

HSP are known to confer protection against diverse forms of cellular injury by having a capacity to bind to misfolded or denatured proteins and thereby prevent their irreversible denaturation (10,11). Although the beneficial effect of heat preconditioning in ischemic injury has been reported in several organs, including the kidney, the precise mechanism of protection remains unclear. Recently, several in vitro and in vivo studies suggested that one of the protective mechanisms of heat preconditioning, or HSP, is their inhibitory effect on NF-{kappa}B–mediated inflammation (19,20). However, the in vivo effect of heat preconditioning on inflammation in the kidney has never been demonstrated. Therefore, we first examined the effect of heat preconditioning on NF-{kappa}B activation and inflammation. Heat preconditioning suppressed I/R-induced NF-{kappa}B activation in the kidney at 1 h after reperfusion. These findings again were confirmed by Western blot analysis of p65 subunit of NF-{kappa}B complexes. Suppression of NF-{kappa}B activation by heat preconditioning at 1 h was accompanied by a subsequent decrease in MCP-1 mRNA and protein expression at 6 h and also by decreased leukocyte recruitment at 24 h. We divided kidney tissues into cortex and medulla by blunt dissection and found that MCP-1 expression increased significantly in medulla, where subsequent inflammation and tubular necrosis were predominant. These results are consistent with other studies (21,22) and support the possibility that heat preconditioning reduces the transcriptional activation of proinflammatory mediators and subsequent inflammation by blocking the activation of the NF-{kappa}B pathway in ischemic ARF. However, there is a limitation of using an activation assay rather than nuclear transcription reporter assay because activation of NF-{kappa}B does not necessarily lead to increased transcription. Although we cannot provide direct evidence in this study, NF-{kappa}B–dependent production of MCP-1 or other cytokines has been demonstrated in several in vitro and in vivo studies (23,24). Cao et al. (23) demonstrated that inhibition of NF-{kappa}B by in vivo transfection of decoy oligodeoxynucleotides not only prevented NF-{kappa}B activation but also decreased MCP-1 gene expression with decreased monocyte/macrophage infiltration. The role of MCP-1 in I/R injury also has been studied extensively, and it is thought to play an important role in leukocyte recruitment with further compromise of the outer medullary reflow and facilitation of tubular cell damage (17,25,26). However, the effect of NF-{kappa}B on facilitating cell survival or inhibiting apoptosis in other cell types also has been reported (27,28). The major pathway for NF-{kappa}B activation depends on the activation of IKK complexes, which leads to the phosphorylation of the serine residue of cytoplasmic I{kappa}B and degradation by the ubiquitin-proteasome system. However, other mechanisms that are not dependent on phosphorylation and degradation of I{kappa}B also have been reported (29). To evaluate further the inhibitory effect of heat preconditioning on NF-{kappa}B pathway, we examined I{kappa}B and phospho-I{kappa}B protein levels that recognize the phosphorylation of serine residue of I{kappa}B, using cytoplasmic protein extracts. We found that the suppression of NF-{kappa}B activation by previous heat preconditioning was secondary to decreased phosphorylation and resultant stabilization of cytoplasmic I{kappa}B. This finding might suggest that the beneficial effect of previous heat preconditioning is mediated by inhibition of IKK activation, an upstream kinase of I{kappa}B that results in inhibition of NF-{kappa}B nuclear translocation. This is in agreement with several other studies (20). However, according to several recent reports, inhibition of I{kappa}B degradation by increased phosphatase activity after heat shock also could be a possible mechanism (30).

Renal tubular cells that are lethally injured after ischemic or toxic insults can die by necrosis or apoptosis (4,31). Contrary to apoptosis, which is a well-coordinated process, necrosis usually results from overwhelming cellular ATP depletion that is beyond their capability to repair and has been known to be an unregulated event. However, recent studies suggest that necrosis also is controlled by a specific program that involves many signaling cascades such as reactive oxygen species and stress kinases (14). In our study using 40-min bilateral ischemia, extensive tubular necrosis in outer medulla was observed at 24 h after I/R, and heat preconditioning significantly decreased tubular necrosis. The mechanisms of heat preconditioning or HSP-mediated cell protection from necrosis is not well understood. The direct inhibitory effect of HSP-72 on c-JUN N-terminal kinase pathways that mediate cell necrosis in addition to their function as molecular chaperones has been suggested by Yaglom et al. (14), and it is possible that induced HSP-70 in our study inhibited c-JUN N-terminal kinase–mediated tubular cell death. Apoptosis is characterized by cell shrinkage, nuclear chromatin condensation, and activation of a family of cysteine proteases called caspase. HSP-70 was reported previously to decrease apoptosis through inhibition of the mitochondrial apoptotic pathway (3234). The in vivo effect of HSP-70 on the mitochondrial apoptotic pathway also was demonstrated by Lee et al. (35), who observed more cytochrome c release into the cytosol with a larger infarct volume in HSP-70 knockout mice in the cerebral ischemia model. Although the inhibitory effect of previous heat stress on caspase 3 activation and apoptosis in ATP-depleted tubular cells has been reported (36), the in vivo effect of heat preconditioning on various caspase activation has never been assessed. Therefore, we measured caspase activation after heat preconditioning or I/R. Caspase 3 activity increased in cortex at 6 h after I/R, and heat preconditioning decreased the activations significantly. Tubular cell apoptosis, determined by TUNEL staining, was observed predominantly in cortical distal tubules and also decreased markedly by heat preconditioning. However, caspase 8 or 9 activity, which represents the activation of membrane death receptor pathway or mitochondrial pathway, did not match with those of caspase 3 (data not shown), indicating that the effect of heat preconditioning is independent of activation of caspase 8 or 9 in I/R-induced ARF. The precise biochemical pathways by which heat preconditioning decreases apoptosis is not clear in this study. Recent studies suggested that HSP-70 precipitates Bcl2, a widely known antiapoptotic protein, and this interaction between HSP-70 and Bcl2 protein may afford cytoprotection by restoring Bcl2 function, a role that is compatible with the chaperone function of this stress protein (37,38).

These above findings suggest that the effect of heat preconditioning might be mediated via inhibition of NF-{kappa}B–mediated inflammation and inhibition of cell death pathways, but there still are uncertainties as to the specificity of individual HSP in these circumstances or the possible nonspecific effects of other HSP molecules. We therefore performed Western blot analysis of various HSP, including HSP-27, HSP-32 (heme oxygenase-1), HSP-70, and HSP-90. In contrast to HSP-27, -32, and -90, which showed a minimal increase after heat stress, HSP-70 protein increased significantly after 1 h and reached a maximum level at 14 h. Quercetin administration, a widely known inhibitor of HSP-70, decreased its expression markedly, and this was accompanied not only by complete reversal of the functional protection that was provided from heat preconditioning at 24 h after I/R but also by reversal of suppression of the p65 subunit of NF-{kappa}B. This observation strongly suggests that the beneficial effect of heat preconditioning is mediated primarily by HSP-70 induction. HSP-70 induction is correlated with the inhibition of NF-{kappa}B. Although the above data can provide evidence of the importance of HSP-70 in renal protection, we further examined the alterations in HSP-70 expression after I/R. It is interesting that we found that HSP-70 expression after I/R was blunted significantly in previously heat-preconditioned rats. The precise mechanism is not clear, but Basile et al. (39) reported that in ischemia-resistant Brown-Norway rats, which have a higher level of constitutive HSP, the induction of HSP-25 and HSP-72 by I/R was blunted and their kidneys were functionally protected from I/R. This finding is comparable with our results and further supports that induced HSP before injury is critical in providing protection.


    Conclusion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 
We have shown that heat preconditioning resulted in attenuation of renal injury. This protective effect was accompanied by inhibition of NF-{kappa}B activation with subsequent decrease in inflammation and also decrease in tubular cell necrosis and apoptosis. HSP-70 is thought to be responsible for this beneficial effect. A better understanding of the role of stress proteins in modifying proinflammatory, proapoptotic mediators could facilitate new drug development for reducing renal injury in ischemic ARF and other diseases.


    Acknowledgments
 
We thank Mr. H.W. Kim, Mrs. Y.S. Ko, and Mrs. K.H. Chang for their excellent technical support.


    Footnotes
 
Published online ahead of print. Publication date available at www.jasn.org.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Conclusion
 References
 

  1. Star RA: Treatment of acute renal failure. Kidney Int 54 : 1817 –1831, 1998[CrossRef][Medline]
  2. Bonventre JV, Weinberg JM: Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14 : 2199 –2210, 2003[Free Full Text]
  3. Okusa MD: The inflammatory cascade in acute ischemic renal failure. Nephron 90 : 133 –138, 2002[CrossRef][Medline]
  4. Lieberthal W, Koh JS, Levine JS: Necrosis and apoptosis in acute renal failure. Semin Nephrol 18 : 505 –518, 1998[Medline]
  5. Bonegio R, Lieberthal W: Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 11 : 301 –308, 2002[CrossRef][Medline]
  6. Barnes PJ, Karin M: Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336 : 1066 –1071, 1997[Free Full Text]
  7. Ishiyama T, Dharmarajan S, Hayama M, Moriya H, Grapperhaus K, Patterson GA: Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg 130 : 194 –201, 2005[Abstract/Free Full Text]
  8. Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, Karjalainen-Lindsberg ML, Weih F, Frank N, Schwaninger M, Koistinaho J: Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 35 : 987 –991, 2004[Abstract/Free Full Text]
  9. Chen F, Castranova V, Shi X: New insights into the role of nuclear factor-kappaB in cell growth regulation. Am J Pathol 159 : 387 –397, 2001[Abstract/Free Full Text]
  10. Agashe VR, Hartl FU: Roles of molecular chaperones in cytoplasmic protein folding. Semin Cell Dev Biol 11 : 15 –25, 2000[CrossRef][Medline]
  11. Hartl FU, Martin J: Molecular chaperones in cellular protein folding. Curr Opin Struct Biol 5 : 92 –102, 1995[CrossRef][Medline]
  12. Malhotra V, Wong HR: Interactions between the heat shock response and the nuclear factor-kappaB signaling pathway. Crit Care Med 30[Suppl] : S89 –S95, 2002[CrossRef][Medline]
  13. Stankiewicz AR, Lachapelle G, Foo CP, Radicioni SM, Mosser DD: Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation. J Biol Chem 280 : 38729 –38739, 2005[Abstract/Free Full Text]
  14. Yaglom JA, Ekhterae D, Gabai VL, Sherman MY: Regulation of necrosis of H9c2 myogenic cells upon transient energy deprivation. Rapid deenergization of mitochondria precedes necrosis and is controlled by reactive oxygen species, stress kinase JNK, HSP72 and ARC. J Biol Chem 278 : 50483 –50496, 2003[Abstract/Free Full Text]
  15. Uchinami H, Yamamoto Y, Kume M, Yonezawa K, Ishikawa Y, Taura K, Nakajima A, Hata K, Yamaoka Y: Effect of heat shock preconditioning on NF-kappaB/I-kappa pathway during I/R injury of the rat liver. Am J Physiol Gastrointest Liver Physiol 282 : G962 –G971, 2002[Abstract/Free Full Text]
  16. Chen Y, Arrigo AP, Currie RW: Heat shock treatment suppresses angiotensin II-induced activation of NF-kappaB pathway and heart inflammation: A role for IKK depletion by heat shock? Am J Physiol Heart Circ Physiol 287 : H1104 –H1114, 2004[Abstract/Free Full Text]
  17. Furuichi K, Wada T, Yokoyama H, Kobayashi KI: Role of cytokines and chemokines in renal ischemia-reperfusion injury. Drug News Perspect 15 : 477 –482, 2002[CrossRef][Medline]
  18. Lee JI, Burckart GJ: Nuclear factor kappa B: Important transcription factor and therapeutic target. J Clin Pharmacol 38 : 981 –993, 1998[Abstract/Free Full Text]
  19. Meldrum KK, Burnett AL, Meng X, Misseri R, Shaw MB, Gearhart JP, Meldrum DR: Liposomal delivery of heat shock protein 72 into renal tubular cells blocks nuclear factor-kappaB activation, tumor necrosis factor-alpha production, and subsequent ischemia-induced apoptosis. Circ Res 92 : 293 –299, 2003[Abstract/Free Full Text]
  20. Yoo CG, Lee S, Lee CT, Kim YW, Han SK, Shim YS: Anti-inflammatory effect of heat shock protein induction is related to stabilization of I kappa B alpha through preventing I kappa B kinase activation in respiratory epithelial cells. J Immunol 164 : 5416 –5423, 2000[Abstract/Free Full Text]
  21. Uchinami H, Yamamoto Y, Kume M, Yonezawa K, Ishikawa Y, Taura K, Nakajima A, Hata K, Yamaoka Y: Effect of heat shock preconditioning on NF-kappaB/I-kappaB pathway during I/R injury of the rat liver. Am J Physiol Gastrointest Liver Physiol 282 : G962 –G971, 2002[Abstract/Free Full Text]
  22. Chen Y, Arrigo AP, Currie RW: Heat shock treatment suppresses angiotensin II-induced activation of NF-kappaB pathway and heart inflammation: A role for IKK depletion by heat shock? Am J Physiol Heart Circ Physiol 287 : H1104 –H1114, 2004[Abstract/Free Full Text]
  23. Cao CC, Ding XQ, Ou ZL, Liu CF, Li P, Wang L, Zhu CF: In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int 65 : 834 –845, 2004[CrossRef][Medline]
  24. Sung FL, Zhu TY, Au-Yeung KK, Siow YL, O K: Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress, NF-kappaB. Kidney Int 62 : 1160 –1170, 2002[CrossRef][Medline]
  25. Rice JC, Spence JS, Yetman DL, Safirstein RL: Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney. Ren Fail 24 : 703 –723, 2002[CrossRef][Medline]
  26. Yamada T, Murase N, Maeda T, Ye Q, Sakamoto T, Terakura M, Starzl TE, Todo S: Protective effect of TNF-alpha and IL-1 beta inhibitor FR167653 on ischemia-reperfusion injury in rat small intestinal transplantation. Transplant Proc 30 : 2638 , 1998[CrossRef][Medline]
  27. Chaisson ML, Brooling JT, Ladiges W, Tsai S, Fausto N: Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J Clin Invest 110 : 193 –202, 2002[CrossRef][Medline]
  28. Yang H, Bocchetta M, Kroczynska B, Elmishad AG, Chen Y, Liu Z, Bubici C, Mossman BT, Pass HI, Testa JR, Franzoso G, Carbone M: TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci U S A 103 : 10392 –10402, 2006
  29. Zwacka RM, Zhang Y, Zhou W, Halldorson J, Engelhardt JF: Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation. Hepatology 28 : 1022 –1030, 1998[CrossRef][Medline]
  30. Grossman BJ, Shanley TP, Odoms K, Dunsmore KE, Denenberg AG, Wong HR: Temporal and mechanistic effects of heat shock on LPS-mediated degradation of IkappaBalpha in macrophages. Inflammation 26 : 129 –137, 2002[CrossRef][Medline]
  31. Lieberthal W, Menza SA, Levine JS: Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am J Physiol 274 : F315 –F327, 1998[Medline]
  32. Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES: Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol 2 : 476 –483, 2000[CrossRef][Medline]
  33. Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, Tailor P, Morimoto RI, Cohen GM, Green DR: Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2 : 469 –475, 2000[CrossRef][Medline]
  34. Steel R, Doherty JP, Buzzard K, Clemons N, Hawkins CJ, Anderson RL: Hsp72 inhibits apoptosis upstream of the mitochondria and not through interactions with Apaf-1. J Biol Chem 279 : 51490 –51499, 2004[Abstract/Free Full Text]
  35. Lee SH, Kwon HM, Kim YJ, Lee KM, Kim M, Yoon BW: Effects of hsp70.1 gene knockout on the mitochondrial apoptotic pathway after focal cerebral ischemia. Stroke 35 : 2195 –2199, 2004[Abstract/Free Full Text]
  36. Wang Y, Knowlton AA, Christensen TG, Shih T, Borkan SC: Prior heat stress inhibits apoptosis in adenosine triphosphate-depleted renal tubular cells. Kidney Int 55 : 2224 –2235, 1999[CrossRef][Medline]
  37. Seidberg NA, Clark RS, Zhang X, Lai Y, Chen M, Graham SH, Kochanek PM, Watkins SC, Marion DW: Alterations in inducible 72-kDa heat shock protein and the chaperone cofactor BAG-1 in human brain after head injury. J Neurochem 84 : 514 –521, 2003[CrossRef][Medline]
  38. Townsend PA, Cutress RI, Sharp A, Brimmell M, Packham G: BAG-1: A multifunctional regulator of cell growth and survival. Biochim Biophys Acta 1603 : 83 –98, 2003[Medline]
  39. Basile DP, Donohoe D, Cao X, Van Why SK: Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection. Kidney Int 65 : 2201 –2211, 2004[CrossRef][Medline]



This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
Y. Yokomaku, T. Sugimoto, S. Kume, S.-i. Araki, K. Isshiki, M. Chin-Kanasaki, M. Sakaguchi, N. Nitta, M. Haneda, D. Koya, et al.
Asialoerythropoietin Prevents Contrast-Induced Nephropathy
J. Am. Soc. Nephrol., February 1, 2008; 19(2): 321 - 328.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005101077v1
17/11/3082    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jo, S.-K.
Right arrow Articles by Kim, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jo, S.-K.
Right arrow Articles by Kim, H. K.


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP